ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL - Concepedia

Concepedia

Publication | Open Access

ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL

DOI Full Paper Access

94

Citations

24

References

2017

Year

Babafemi Taiwo, Lu Zheng, Andrei Ștefănescu, Amesika N. Nyaku, Baiba Bezins, Carole L. Wallis, Catherine Godfrey, Paul E. Sax, Edward P. Acosta, David W. Haas,

Clinical Infectious Diseases

Abstract

NCT02582684.

References

	Year	Citations

Page 1